Clinical Trials
7 trialsNCT01313559 2025-04-30
Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer
Thomas Jefferson University
Phase 2 Terminated
NCT01051570 2020-12-01
Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After Docetaxel
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00976755 2019-08-09
Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer
Swiss Cancer Institute
Phase 2 Completed
NCT00526591 2018-12-06
Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer
Case Comprehensive Cancer Center
Phase 2 Terminated
NCT00814788 2018-01-10
UCDCC#215
University of California, Davis
Phase 2 Completed
NCT00630344 2017-12-08
RAD001 and Bicalutamide for Androgen Independent Prostate Cancer
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00657982 2009-01-21
Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer
Sheba Medical Center
Phase 2 Unknown